Immunotherapy: Open Access
Open Access
ISSN: 2471-9552
ISSN: 2471-9552
Dr. Daniel Olive, MD, PhD
Executive Editor
Professor
Aix Marseille University, France
Daniel Olive is professor of immunology at Aix Marseille University. He is also in charge of the "Immunity and Cancer" research team of INSERM UMR1068 of Marseille Cancer Research Center (Institut Paoli Calmettes). He is the head of the first IBiSA Platform dedicated to Cancer Immunomonitoring Platform. Daniel Olive has been a pioneer and leader in the co-signalling field since 1990. His work is dedicated to tumor immunology with a major emphasis on innate immunity and co-signalling molecules. He has completed his post doctoral studies from Ludwig Institute for Cancer Research Lausanne in the field of immunology (1985-1986).
Daniel Olive is professor of immunology at Aix Marseille University. He is also in charge of the "Immunity and Cancer" research team of INSERM UMR1068 of Marseille Cancer Research Center (Institut Paoli Calmettes). He is the head of the first IBiSA Platform dedicated to Cancer Immunomonitoring Platform. Daniel Olive has been a pioneer and leader in the co-signalling field since 1990. His work is dedicated to tumor immunology with a major emphasis on innate immunity and co-signalling molecules. He has completed his post doctoral studies from Ludwig Institute for Cancer Research Lausanne in the field of immunology (1985-1986).